BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12789280)

  • 1. Genetics of melanoma predisposition.
    Hayward NK
    Oncogene; 2003 May; 22(20):3053-62. PubMed ID: 12789280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics in melanoma.
    Stahl S; Bar-Meir E; Friedman E; Regev E; Orenstein A; Winkler E
    Isr Med Assoc J; 2004 Dec; 6(12):774-7. PubMed ID: 15609895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High- and low-penetrance cutaneous melanoma susceptibility genes.
    Fargnoli MC; Argenziano G; Zalaudek I; Peris K
    Expert Rev Anticancer Ther; 2006 May; 6(5):657-70. PubMed ID: 16759158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes involved in melanoma: an overview of INK4a and other loci.
    Castellano M; Parmiani G
    Melanoma Res; 1999 Oct; 9(5):421-32. PubMed ID: 10596908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
    Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA
    Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
    Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D
    Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
    Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J
    Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
    Ghiorzo P; Pastorino L; Pizzichetta MA; Bono R; Queirolo P; Talamini R; Annessi G; Bruno W; Nasti S; Gargiulo S; Battistuzzi L; Sini MC; Palmieri G; Scarrà GB;
    Melanoma Res; 2009 Jun; 19(3):142-5. PubMed ID: 19339902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma etiology: where are we?
    Tucker MA; Goldstein AM
    Oncogene; 2003 May; 22(20):3042-52. PubMed ID: 12789279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
    Pho L; Grossman D; Leachman SA
    Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of melanoma susceptibility.
    Ghiorzo P; Scarrà GB
    Forum (Genova); 2003; 13(2):114-22; quiz 187. PubMed ID: 14732879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline melanoma susceptibility and prognostic genes: a review of the literature.
    Ward KA; Lazovich D; Hordinsky MK
    J Am Acad Dermatol; 2012 Nov; 67(5):1055-67. PubMed ID: 22583682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds.
    Flores JF; Pollock PM; Walker GJ; Glendening JM; Lin AH; Palmer JM; Walters MK; Hayward NK; Fountain JW
    Oncogene; 1997 Dec; 15(24):2999-3005. PubMed ID: 9416844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of pigmentation and melanoma predisposition.
    Pho LN; Leachman SA
    G Ital Dermatol Venereol; 2010 Feb; 145(1):37-45. PubMed ID: 20197744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations.
    Box NF; Duffy DL; Chen W; Stark M; Martin NG; Sturm RA; Hayward NK
    Am J Hum Genet; 2001 Oct; 69(4):765-73. PubMed ID: 11500805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi.
    Papp T; Pemsel H; Zimmermann R; Bastrop R; Weiss DG; Schiffmann D
    J Med Genet; 1999 Aug; 36(8):610-4. PubMed ID: 10465111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of germline CDK6 mutations in familial melanoma.
    Shennan MG; Badin AC; Walsh S; Summers A; From L; McKenzie M; Goldstein AM; Tucker MA; Hogg D; Lassam N
    Oncogene; 2000 Mar; 19(14):1849-52. PubMed ID: 10777219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and environmental factors in cutaneous malignant melanoma.
    Bressac-de-Paillerets B; Avril MF; Chompret A; Demenais F
    Biochimie; 2002 Jan; 84(1):67-74. PubMed ID: 11900878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
    Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
    Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.